Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

InterbrandHealth

- PMLiVE

Pfizer’s Inlyta gets EU approval for advanced kidney cancer

Available as second-line therapy after treatment with pharma firm's own Sutent

- PMLiVE

Pfizer dealt another blow as Torisel fails kidney cancer trial

Results are another setback in company's bid to extend the indications for its mTOR inhibitor

AstraZeneca and BGT shelve experimental sepsis drug

Decision follows CytoFab’s poor mid-stage clinical trial results

- PMLiVE

End of the line for intravenous bapineuzumab in Alzheimer’s

Negative trial results for Pfizer and Johnson & Johnson to concede defeat

- PMLiVE

Pfizer sells Kent R&D centre to property consortium

Discovery Park Ltd takes over site 18 months after US pharma firm announced plans to exit it

- PMLiVE

Anatomy of your brand

In his feature Dissecting the anatomy of your brand, Kevin talks about ways to add value to your product. Now apply that thinking…

- PMLiVE

7 steps to (briefing) heaven

Don't let your campaign get off to a false start. These seven steps will help you write a creative brief with clarity.

- PMLiVE

Discover strategic opportunities

How to reach your end-goal… and the steps needed to get you there. Two foremost agency directors talk you through the way to get from A to B.

- PMLiVE

Create a brief that delivers

Eight important steps to ensure you produce a brief for your agency that contains all the important elements. Plus, your Instant Expert quick checklist to keep you on track.

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links